UMB Bank’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7K Buy
414
+9
+2% +$210 ﹤0.01% 1886
2026
Q1
$7.73K Buy
405
+217
+115% +$4.8K ﹤0.01% 1940
2025
Q4
$4.55K Buy
188
+22
+13% +$576 ﹤0.01% 2037
2025
Q3
$4.24K Sell
166
-5
-3% -$119 ﹤0.01% 1917
2025
Q2
$3.68K Buy
171
+46
+37% +$1.04K ﹤0.01% 1902
2025
Q1
$2.85K Buy
125
+35
+39% +$922 ﹤0.01% 1908
2024
Q4
$2.34K Buy
90
+10
+13% +$249 ﹤0.01% 1904
2024
Q3
$2K Buy
80
+33
+70% +$779 ﹤0.01% 1982
2024
Q2
$1.01K Buy
47
+29
+161% +$563 ﹤0.01% 1970
2024
Q1
$334 Buy
+18
New +$315 ﹤0.01% 2065
2022
Q2
Sell
-63
Closed -$1K 1904
2022
Q1
$1K Buy
+63
New +$1.66K ﹤0.01% 1886

Other funds holding BLFS

UMB Bank's BLFS Position: Q2 2026 in Review

UMB Bank increased its BioLife Solutions (BLFS) stake by 2.2% in Q2 2026, buying an estimated $210 and bringing the position to 414 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

UMB Bank first reported a position in BLFS in Q1 2022 and has held it in 11 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • UMB Bank held 414 shares of BioLife Solutions worth $11.7K as of Q2 2026.
  • UMB Bank bought 9 BioLife Solutions shares in Q2 2026, an estimated $210.
  • BioLife Solutions made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1886 holding.
  • UMB Bank first reported a position in BioLife Solutions in Q1 2022 and has held it in 11 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.